SCHEMBL7769219

SCHEMBL7769219

NC(CN1CCN(Cc2ccccc2)CC1)c1nc2ccc(F)cc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.45
DRD2 P14416 3/20 0.44
KCNH2 Q12809 3/20 0.44
SLC39A7 Q92504 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
ACHE P22303 1/20 0.40
BACE1 P56817 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.39
AXL P30530 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27565702 0.93 DRD2 (0.49) NPC1RAB9AMEN1KMT2AKDM4E
Fumaric Acid SCHEMBL7776854 0.92 ALDH1A1 (0.42) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL7773194 0.90 KCNH2 (0.44) NPC1RAB9ADRD2KCNH2HTR3E
Bromide SCHEMBL7773390 0.89 KCNH2 (0.43) NPC1RAB9ADRD2KCNH2HTR3E
SCHEMBL27565726 0.87 NPC1 (0.44) NPC1RAB9AMEN1KMT2AKDM4E
Bromide SCHEMBL7773488 0.86 NPC1 (0.43) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL7773430 0.84 CSNK1D (0.46) MEN1KMT2AKDM4EHTTDRD2
Bromide SCHEMBL7775344 0.83 CSNK1D (0.46) MEN1KMT2AKDM4EHTTDRD2
SCHEMBL7775357 0.82 CSNK1D (0.37)
SCHEMBL7775455 0.82 NPC1 (0.44) NPC1RAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN disclosed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed